fda drug safety communication naion semaglutide 2025 November Safety: Recalls for Compounded Semaglutide, Generic Synthroid; updates for Lamictal, Kineret, Miebo eye drops, Zoladex; Microneedling Injuries, more FDA Warns Novo Nordisk of

If these effects are too extreme, Batash recommends either lowering the dosage or stopping usage altogether

Rapid weight reduction, shifts in hormones, and alterations in metabolism may all cause some users to suffer from irregular periods

In structured programs, strength training is often performed two to four times per week, alongside adequate protein intake

Common side effects include nausea, vomiting, diarrhea, constipation, fatigue, and in some cases, muscle loss

,

In 2021, Semaglutide and Tirzepatide were FDA-approved to help with weight loss with the injectable treatment known under the brand names WeGovy and Mounjaro